BlackRock Fund Advisors’s BIND THERAPEUTICS INC BIND Stock Holding History

BlackRock Fund Advisors’s Portfolio BIND Stock Details BIND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-32,627	Closed	-$72K	–	4417
2016 Q1	$72K	Sell	32,627 -2,518	-7%	-$4.57K	﹤0.01%	3737
2015 Q4	$80K	Buy	35,145 +1,291	+4%	+$5.22K	﹤0.01%	3786
2015 Q3	$151K	Buy	33,854 +5,654	+20%	+$27.7K	﹤0.01%	3582
2015 Q2	$158K	Buy	28,200 +9,162	+48%	+$56.8K	﹤0.01%	3618
2015 Q1	$105K	Sell	19,038 -1,296	-6%	-$7.96K	﹤0.01%	3621
2014 Q4	$110K	Buy	20,334 +5,254	+35%	+$39.4K	﹤0.01%	3607
2014 Q3	$130K	Sell	15,080 -1,088	-7%	-$10.7K	﹤0.01%	3597
2014 Q2	$213K	Sell	16,168 -136,344	-89%	-$1.33M	﹤0.01%	3467
2014 Q1	$1.82M	Buy	152,512 +11,476	+8%	+$150K	﹤0.01%	3146
2013 Q4	$2.13M	Buy	+141,036	New	+$1.79M	﹤0.01%	3135

Other funds holding BIND

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FMA

FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

BlackRock Fund Advisors's BIND Position: Q2 2016 in Review

BlackRock Fund Advisors sold out of BIND THERAPEUTICS INC (BIND) in Q2 2016, closing a stake of 32,627 shares — an estimated $72K sold.

BlackRock Fund Advisors first reported a position in BIND in Q4 2013 and held it in 10 quarters. The position peaked at $2.13M in Q4 2013. 21 funds tracked by Wall St. Rank hold BIND as of Q2 2016.

BlackRock Fund Advisors reported no remaining BIND THERAPEUTICS INC position as of Q2 2016 after selling out during the quarter.
BlackRock Fund Advisors sold 32,627 BIND THERAPEUTICS INC shares in Q2 2016, an estimated $72K.
BlackRock Fund Advisors first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 10 quarters.
BlackRock Fund Advisors's BIND THERAPEUTICS INC position peaked at $2.13M in Q4 2013.
21 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q2 2016.

Based on BlackRock Fund Advisors's 13F filing for Q2 2016, filed 10 Aug 2016.